Neogen Chemicals Limited has informed the Exchange regarding a press release dated May 17, 2026, titled "Neogen Chemicals reports strong financial performanceRevenue at INR 247 crore, higher by 22% Y-o-YBoard recommended a final dividend of INR 1 per equity share for FY26".
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Neogen Chemicals reported strong Q4 FY26 consolidated revenue of INR 247 crore, up 22% Y-o-Y, with EBITDA of INR 44 crore (+21%) and PAT of INR 11 crore (+373% boosted by a low base from Q4 FY25 Dahej fire-related one-off costs). Full-year FY26 revenue stood at INR 862 crore (+11%), though EBITDA grew only 1% and PAT declined 17% to INR 29 crore due to Dahej plant transition costs, elevated input costs from geopolitical supply chain disruptions, and Neogen Ionics expansion overheads. EBITDA margin sustained at 17.8% in Q4. The Board recommended a dividend of INR 1 per share. Promoter infusion of INR 161 crore via preferential allotment supports the battery materials expansion. Dahej replacement plant commissioning is expected by June 2026. FY27 revenue guidance is INR 875–950 crore.
Strong Q4 topline and PAT recovery are positives, but full-year PAT decline and minimal EBITDA growth despite higher revenues signal margin compression. The INR 161 crore promoter capital infusion and battery materials expansion (Pakhajan plant on track for H1 FY27 electrolyte commissioning) are encouraging long-term catalysts. Near-term focus is on Dahej plant commissioning and scaling Neogen Ionics.